![](/img/cover-not-exists.png)
LBA30COMPREHENSIVE ANALYSIS OF SERUM BIOMARKER AND TUMOR GENE MUTATION ASSOCIATED WITH CLINICAL OUTCOMES IN THE PHASE 3 STUDY OF (E7080) LENVATINIB IN DIFFERENTIATED CANCER OF THE THYROID (SELECT)
Tahara, M., Schlumberger, M., Wirth, L.J., Elisei, R., Brose, M., Habra, M.A., Newbold, K., Kiyota, N., Dutcus, C., Zhu, J., Kadowaki, T., Funahashi, Y., Robinson, B., Sherman, S.Volume:
25
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu438.31
Date:
September, 2014
File:
PDF, 66 KB
2014